- Home
- BRNS vs TXMD Comparison
BRNS vs TXMD Comparison
Compare BRNS & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BRNS | TXMD |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1M | 24.4M |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | BRNS | TXMD |
|---|---|---|
| Price | $0.61 | $2.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 31.0K | 17.4K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 73.68 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $104.00 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $0.51 | $0.99 |
| 52 Week High | $1.83 | $2.95 |
Technical Indicators
Market Signals| Indicator | BRNS | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 50.29 | 53.18 |
| Support Level | $0.55 | $2.07 |
| Resistance Level | $0.62 | $2.11 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 80.00 | 34.57 |
Price Performance
Historical ComparisonAbout BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.